With lifestyle disorders and non-communicable diseases on the rise, many people routinely undergo Liver Function Tests (LFTs) ...
LFTs are a panel of blood tests that help detect liver injury, cholestasis or synthetic dysfunction. Learn what each marker ...
Vertex Pharmaceuticals Incorporated today announced the presentation of multiple abstracts demonstrating the clinical benefits of treatment with CFTR modulators, including the Company's most recently ...
MedPage Today on MSN
Trial Questions Ketamine Use for Patients Hospitalized With Depression
A 2022 study showed that 28.3% of patients receiving ketamine had a billing diagnosis of depression. McLoughlin's group ...
After Intellia Therapeutics paused a pair of phase 3 trials for its CRISPR therapy in response to a liver safety signal, the ...
By Deanna Neff HealthDay ReporterMONDAY, Oct. 27, 2025 (HealthDay News) — The U.S. Food and Drug Administration (FDA) has ...
The U.S. Food and Drug Administration has approved elinzanetant, a new non-hormonal treatment to help women manage menopause ...
Elinzanetant belongs to a new class of drugs designed to target what is believed to be a key mechanism responsible for ...
The natural wellness culture has blurred the line between traditional medicine and commercial marketing. The message is ...
That subtle dark line across the back of the neck might seem just a skin-matter. We might think it is because the clothes we ...
Terns Pharmaceuticals (TERN) announced topline 12-week results from its Phase 2 trial of TERN-601, a novel, once-daily, oral GLP-1 receptor ...
Background/Aims The neuroprotective effect of nicotinamide (NAM) supplementation has been demonstrated in both animal models ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback